Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer. (NCT05719779)

🧪 Interventions in This Study

• Ronco-Onco and MAD (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• CHUM — Montreal, Quebec

📞 Contact the Study Coordinator

Phone: (514) 343-2310

Email: gilles.lavigne@umontreal.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Oral Cancer

• Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial — New Brunswick, New Jersey
• Radial Forearm Donor Site Closure — Vancouver, British Columbia
• Enhancing Oral Cancer Awareness — Richmond, Virginia
• Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain — New York, New York
• Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction — Cleveland, Ohio

Explore by condition: All Oral Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.